Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Organogenesis Holdings Inc (NASDAQ: ORGO) closed at $5.01 in the last session, down -4.57% from day before closing price of $5.25. In other words, the price has decreased by -$4.57 from its previous closing price. On the day, 1.04 million shares were traded. ORGO stock price reached its highest trading level at $5.4 during the session, while it also had its lowest trading level at $4.99.
Ratios:
We take a closer look at ORGO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 152.01. For the most recent quarter (mrq), Quick Ratio is recorded 3.35 and its Current Ratio is at 3.69. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on June 28, 2024, initiated with a Buy rating and assigned the stock a target price of $5.
On February 07, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $5.
On June 15, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $5.Morgan Stanley initiated its Equal-Weight rating on June 15, 2023, with a $5 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Driscoll Michael Joseph sold 25,000 shares for $5.10 per share. The transaction valued at 127,535 led to the insider holds 166,879 shares of the business.
Gillheeney Gary S. sold 55,615 shares of ORGO for $186,866 on Dec 13 ’24. The President and CEO now owns 3,044,779 shares after completing the transaction at $3.36 per share. On Dec 16 ’24, another insider, Gillheeney Gary S., who serves as the President and CEO of the company, sold 5,585 shares for $3.49 each. As a result, the insider received 19,492 and left with 3,039,194 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGO now has a Market Capitalization of 635408320 and an Enterprise Value of 665259712. As of this moment, Organogenesis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 894.64, and their Forward P/E ratio for the next fiscal year is 26.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.32 while its Price-to-Book (P/B) ratio in mrq is 2.40. Its current Enterprise Value per Revenue stands at 1.38 whereas that against EBITDA is 17.26.
Stock Price History:
The Beta on a monthly basis for ORGO is 1.71, which has changed by 0.82181823 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, ORGO has reached a high of $6.71, while it has fallen to a 52-week low of $2.16. The 50-Day Moving Average of the stock is 30.58%, while the 200-Day Moving Average is calculated to be 55.87%.
Shares Statistics:
According to the various share statistics, ORGO traded on average about 1.71M shares per day over the past 3-months and 1788590 shares per day over the past 10 days. A total of 125.73M shares are outstanding, with a floating share count of 64.38M. Insiders hold about 49.24% of the company’s shares, while institutions hold 49.46% stake in the company. Shares short for ORGO as of 1740700800 were 8621099 with a Short Ratio of 5.05, compared to 1738281600 on 8754353. Therefore, it implies a Short% of Shares Outstanding of 8621099 and a Short% of Float of 28.799999999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
